Health Care
Commentary
Trump is fighting Biden’s drug-price battle — but patients will pay the cost
The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat for former President Joe Biden and his signature legislative accomplishment. Senior Justice officials say they’ll head to court to stick up for Biden’s Inflation Reduction Act and its price controls on prescription drugs. ...
Blog
Read the latest about the problems with single-payer health care
Single-Payer Systems Fail Children and Cancer Patients
But the real test of any healthcare system is whether it delivers timely, effective care. And in their latest installments in the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems,” Douglas Holtz-Eakin and Michael Baker investigate that question in two key areas: pediatrics and cancer. Holtz-Eakin dives into ...
Commentary
Medicare fraud should be next in line for DOGE
The Department of Government Efficiency’s crackdown on waste, fraud and abuse is off to a fast start. But as an engine of government savings, DOGE still has substantial untapped potential. That’s because it hasn’t yet addressed the fraud crippling one of the federal government’s largest programs: Medicare. In fiscal year ...
Commentary
Republicans’ Free Chance To Save Sick Kids
Right now, Congress has a chance to save the lives of countless sick children—without spending a dime of taxpayer money. It could seize that opportunity by reauthorizing the Pediatric Priority Review Voucher (PPRV) program—which incentivizes companies to invest in lifesaving but financially risky treatments for rare pediatric diseases. Read the ...
Commentary
In defense of Medicaid work requirements
Republicans are considering cuts to Medicaid, the joint federal-state health plan that provides taxpayer-funded health coverage to 80 million adults and children. Many in the GOP would like to require able-bodied Medicaid beneficiaries to work in exchange for coverage. That’s a good idea. Read the entire op-ed here.
Commentary
Make Telehealth Coverage a Permanent Medicare Feature
When the Trump administration loosened telemedicine restrictions for Medicare patients in March 2020, the move was seen as temporary. The COVID-19 pandemic was in its early days. Read the op-ed here:
Biosimilars
Fixing The Regulatory Flaws Biosimilars Face Will Help Patients
About a month ago, the Centers for Medicare & Medicaid Services announced the next 15 drugs that will be subject to the maximum fair price (MFP) negotiation process. These negotiations are essentially a means to impose price controls on selected medicines. If the Trump Administration truly wants to help patients, ...
Commentary
We Can’t Afford Timidity in Revamping Medicaid
Last week, the House of Representatives passed a budget resolution by the narrowest of margins. The most controversial component of the bill concerns Medicaid. Democrats have castigated the resolution on the grounds that it would make steep cuts to the joint federal-state public healthcare entitlement. Even some Republicans have expressed ...
Commentary
President and Congress Should Eliminate Wasteful Healthcare Subsidies
Big insurers are beginning to panic. At the end of this year, the generous COVID-era taxpayer subsidies they’ve enjoyed on coverage sold through Obamacare’s exchanges will expire. Good. The subsidies represent billions of dollars in corporate welfare for insurance companies — and obscure how premiums have surged under Obamacare. Read ...
Drug Importation
Sally Pipes – The World’s Medicine Chest
This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
Trump is fighting Biden’s drug-price battle — but patients will pay the cost
The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat for former President Joe Biden and his signature legislative accomplishment. Senior Justice officials say they’ll head to court to stick up for Biden’s Inflation Reduction Act and its price controls on prescription drugs. ...
Read the latest about the problems with single-payer health care
Single-Payer Systems Fail Children and Cancer Patients
But the real test of any healthcare system is whether it delivers timely, effective care. And in their latest installments in the American Action Forum’s “Reality Check-Up: The Truth About Single-Payer Systems,” Douglas Holtz-Eakin and Michael Baker investigate that question in two key areas: pediatrics and cancer. Holtz-Eakin dives into ...
Medicare fraud should be next in line for DOGE
The Department of Government Efficiency’s crackdown on waste, fraud and abuse is off to a fast start. But as an engine of government savings, DOGE still has substantial untapped potential. That’s because it hasn’t yet addressed the fraud crippling one of the federal government’s largest programs: Medicare. In fiscal year ...
Republicans’ Free Chance To Save Sick Kids
Right now, Congress has a chance to save the lives of countless sick children—without spending a dime of taxpayer money. It could seize that opportunity by reauthorizing the Pediatric Priority Review Voucher (PPRV) program—which incentivizes companies to invest in lifesaving but financially risky treatments for rare pediatric diseases. Read the ...
In defense of Medicaid work requirements
Republicans are considering cuts to Medicaid, the joint federal-state health plan that provides taxpayer-funded health coverage to 80 million adults and children. Many in the GOP would like to require able-bodied Medicaid beneficiaries to work in exchange for coverage. That’s a good idea. Read the entire op-ed here.
Make Telehealth Coverage a Permanent Medicare Feature
When the Trump administration loosened telemedicine restrictions for Medicare patients in March 2020, the move was seen as temporary. The COVID-19 pandemic was in its early days. Read the op-ed here:
Fixing The Regulatory Flaws Biosimilars Face Will Help Patients
About a month ago, the Centers for Medicare & Medicaid Services announced the next 15 drugs that will be subject to the maximum fair price (MFP) negotiation process. These negotiations are essentially a means to impose price controls on selected medicines. If the Trump Administration truly wants to help patients, ...
We Can’t Afford Timidity in Revamping Medicaid
Last week, the House of Representatives passed a budget resolution by the narrowest of margins. The most controversial component of the bill concerns Medicaid. Democrats have castigated the resolution on the grounds that it would make steep cuts to the joint federal-state public healthcare entitlement. Even some Republicans have expressed ...
President and Congress Should Eliminate Wasteful Healthcare Subsidies
Big insurers are beginning to panic. At the end of this year, the generous COVID-era taxpayer subsidies they’ve enjoyed on coverage sold through Obamacare’s exchanges will expire. Good. The subsidies represent billions of dollars in corporate welfare for insurance companies — and obscure how premiums have surged under Obamacare. Read ...
Sally Pipes – The World’s Medicine Chest
This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
